Isotopia Announces Official Commercial Launch of Isoprotrace® in Germany in Partnership with DSD Pharma

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Isotopia

More Like This

PR Newswire associated0

Isotopia Announces the UK Launch of Isoprotrace®, an Innovative Diagnostic Solution for Prostate Cancer Imaging

PR Newswire associated0

Isotopia Molecular Imaging Ltd. is thrilled to announce that Isoprotrace®, has received marketing authorization in the Netherlands (RVG 130527)

PR Newswire associated0

Kinectrics and Isotopia Enter Agreement for Supply of Gadolinium-160 (Gd-160) to Support Production of Terbium-161 (Tb-161) for Advanced Radiotherapeutics

PR Newswire associated0

Breakthrough in Lupus Treatment: Isotopia Partners with LIVEKIDNEY.BIO

PR Newswire associated0

Telix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals

Blue Earth Diagnostics Ltd Collaborates with Sinotau Pharmaceutical Group to Bring Prostate Cancer PET Diagnostic Imaging Agent, Flotufolastat (18F) Injection, to China

PR Newswire associated0

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

PR Newswire associated0

Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America